Latest News | Nov 25, 2019

The Week in Review in Prescription Drug Pricing

1. We Could Do This For So Much Less

2. Betrayal

3. Forced to Buy High

4. “Most new drugs aren’t that innovative.”

5. Congress, Please Wake Up

1. “Why is the price so high?”

2. Something Must Change

3. OK, Pharma

4. False Claims Exposed

5. Forced to Ration

It’s a good week when the government stands up to Big Pharma patent predators.

1. PrEP Yourself For a Showdown

2. The Struggle is Real

3. It’s Not Working

4. Her Insulin Costs More Than Her Mortgage

5. 2020

COLUMBUS — As rising drug prices continue to crush patients and the window for Congress to act closes, Patients For Affordable Drugs Now expanded its multi-million dollar campaign to Ohio to ask Sen. Rob Portman to call for a vote on a key bill in the Senate that would protect Americans from unjustified drug price hikes.

Watch the ad campaign video, “Ashley.”

Currently, the average American pays two to three times more for prescription drugs than citizens in other wealthy countries. The Prescription Drug Pricing Reduction Act of 2019 would curtail runaway price hikes in America and cap out-of-pocket costs for patients on Medicare, who can face more than $15,000 a year in drug costs.

“President Trump supports the Senate bill, and now we’re asking Senator Portman to call for a vote on this important bipartisan legislation,” said David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs Now. “Patients need the senator to stand up for them and lower drug prices now.”

These ads come on the heels of a campaign in August when Patients For Affordable Drugs Now thanked Sen. Portman for supporting the Prescription Drug Pricing Reduction Act of 2019 in the Senate Finance committee.

Now, today’s ads — featuring patients speaking out in support of the Senate bill — encourage him to keep up the fight and call for a vote. In addition to paid media, the effort features visits from patients to Washington to share their stories in person and gives patients a suite of tools to contact their representatives in support of lowering drug prices.

Big Pharma is spending millions to distort, demonize, and relentlessly attack these proposals because the changes could actually break the rigged system that keeps their profits high and patients costs skyrocketing.

Americans overwhelmingly support action to lower drug prices. Eighty-six percent of Americans — majorities of Democrats, Republicans, and Independents — support allowing Medicare to negotiate. Nearly 1 in 3 adults report not taking their medicines as prescribed due to cost.

The mission of Patients For Affordable Drugs Now is to educate the public and mobilize patients to advocate for policies to curb runaway drug prices in America. Touted by The Hill as “a leading drug pricing advocacy group,” Patients For Affordable Drugs Now is a bipartisan non-profit organization established under Section 501(c)(4) of the Internal Revenue Service code. As a 501(c)(4), P4ADNow engages in electoral activity and direct advocacy in support of legislation that would lower drug prices.

###

DES MOINES — As rising drug prices continue to crush patients and the window for Congress to act closes, Patients For Affordable Drugs Now expanded its multi-million dollar campaign into Iowa to ask Sen. Joni Ernstto support a key bill in the Senate that would protect Americans from unjustified drug price hikes.

Watch the ad campaign video, “Ashley.”

Currently, the average American pays two to three times more for prescription drugs than citizens in other wealthy countries. The Prescription Drug Pricing Reduction Act of 2019 would curtail runaway price hikes in America and cap out-of-pocket costs for patients on Medicare, who can face more than $15,000 a year in drug costs.

“President Trump supports the Senate bill, and now we’re asking Sen. Ernst to join in calling for a vote on this important bipartisan legislation,” said David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs Now. “Patients are asking her to stand with us — not Big Pharma.”

Today’s ads are part of the multi-million dollar campaign Patients For Affordable Drugs Now launched last month that features patients speaking out in support of proposals in the House and Senate to rein in skyrocketing drug prices. In August, P4ADNow thanked GOP members, including Sen. Chuck Grassley, for supporting reforms.

The campaign features TV, digital, and radio ads across the country that show the toll high prescription drug prices are taking on everyday Americans. In addition to paid media, the effort features visits from patients to Washington to share their stories in person and gives patients a suite of tools to contact their representatives in support of lowering drug prices.

Big Pharma is spending millions to distort, demonize, and relentlessly attack these proposals because the changes could actually break the rigged system that keeps pharma profits high and patients’ costs skyrocketing.

Americans overwhelmingly support action to lower drug prices. Eighty-six percent of Americans — majorities of Democrats, Republicans, and Independents — support allowing Medicare to negotiate. Nearly 1 in 3 adults report not taking their medicines as prescribed due to cost.

The mission of Patients For Affordable Drugs Now is to educate the public and mobilize patients to advocate for policies to curb runaway drug prices in America. Touted by The Hill as “a leading drug pricing advocacy group,” Patients For Affordable Drugs Now is a bipartisan non-profit organization established under Section 501(c)(4) of the Internal Revenue Service code. As a 501(c)(4), P4ADNow engages in electoral activity and direct advocacy in support of legislation that would lower drug prices.

###

COLUMBIA — As rising drug prices continue to crush patients and the window for Congress to act closes, Patients For Affordable Drugs Now expanded its multi-million campaign into South Carolina to ask Sen. Lindsey Grahamto support a key bill in the Senate that would protect Americans from unjustified drug price hikes.
 
Watch the ad campaign video, “Ashley.”

Currently, the average American pays two to three times more for prescription drugs than citizens in other wealthy countries. The Prescription Drug Pricing Reduction Act of 2019 would curtail runaway price hikes in America and cap out-of-pocket costs for patients on Medicare, who can face more than $15,000 a year in drug costs.
 
“President Trump supports the Senate bill, and now we’re asking Senator Graham to join in calling for a vote on this important bipartisan legislation,” said David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs Now. “Patients are asking him to stand with us — not Big Pharma.”

Earlier this year, Sen. Graham’s leadership helped guide a package of bills out of the Senate Judiciary Committee that would stop drug company abuses of our patent system.
 
Today’s ads are part of the multi-million dollar campaign Patients For Affordable Drugs Now launched last month that features patients speaking out in support of proposals in the House and Senate to rein in skyrocketing drug prices. The campaign features TV, digital, and radio ads across the country that show the toll high prescription drug prices are taking on everyday Americans. In addition to paid media, the effort features visits from patients to Washington to share their stories in person and gives patients a suite of tools to contact their representatives in support of lowering drug prices.
 
Big Pharma is spending millions to distort, demonize, and relentlessly attack these proposals because the changes could actually break the rigged system that keeps pharma profits high and patients’ costs skyrocketing.
 
Americans overwhelmingly support action to lower drug prices. Eighty-six percent of Americans — majorities of Democrats, Republicans, and Independents — support allowing Medicare to negotiate. Nearly 1 in 3 adults report not taking their medicines as prescribed due to cost.

The mission of Patients For Affordable Drugs Now is to educate the public and mobilize patients to advocate for policies to curb runaway drug prices in America. Touted by The Hill as “a leading drug pricing advocacy group,” Patients For Affordable Drugs Now is a bipartisan non-profit organization established under Section 501(c)(4) of the Internal Revenue Service code. As a 501(c)(4), P4ADNow engages in electoral activity and direct advocacy in support of legislation that would lower drug prices.

###

TALLAHASSEE — Big Pharma is furiously lobbying Washington to protect its profits, but Sen. Rick Scott is fighting for patients as he works to lower drug prices. That’s why today, Patients For Affordable Drugs Now launched a campaign to thank Sen. Scott for his leadership in the fight to lower drug prices and encourage him to support a key Senate bill that would protect Americans from unjustified drug price hikes.
 
Watch the ad campaign video, “Ashley.”

Currently, the average American pays two to three times more for prescription drugs than citizens in other wealthy countries. The Prescription Drug Pricing Reduction Act of 2019 would curtail runaway price hikes in America and cap out-of-pocket costs for patients on Medicare, who can face more than $15,000 a year in drug costs.
 
“Senator Scott has been standing up to Big Pharma since he got to Washington, through his support of the We PAID Act and the Transparent Drug Pricing Act,” said David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs Now. “President Trump supports the bipartisan Senate bill, and now we’re asking Senator Scott to join in cosponsoring it. We want him to know that patients have his back.” 
 
Today’s ads are part of the multi-million dollar campaign Patients For Affordable Drugs Now launched last month that features patients speaking out in support of proposals in the House and Senate to rein in skyrocketing drug prices. The campaign features TV, digital, and radio ads across the country that show the toll high prescription drug prices are taking on everyday Americans. In addition to paid media, the effort features visits from patients to Washington to share their stories in person and gives patients a suite of tools to contact their representatives in support of lowering drug prices.
 
Big Pharma is spending millions to distort, demonize, and relentlessly attack these proposals because the changes could actually break the rigged system that keeps pharma profits high and patients’ costs skyrocketing.
 
Americans overwhelmingly support action to lower drug prices. Eighty-six percent of Americans — majorities of Democrats, Republicans, and Independents — support allowing Medicare to negotiate. Nearly 1 in 3 adults report not taking their medicines as prescribed due to cost.

The mission of Patients For Affordable Drugs Now is to educate the public and mobilize patients to advocate for policies to curb runaway drug prices in America. Touted by The Hill as “a leading drug pricing advocacy group,” Patients For Affordable Drugs Now is a bipartisan non-profit organization established under Section 501(c)(4) of the Internal Revenue Service code. As a 501(c)(4), P4ADNow engages in electoral activity and direct advocacy in support of legislation that would lower drug prices.

###

SALT LAKE CITY — Big Pharma is furiously lobbying Washington to protect its profits, but Sens. Mitt Romney and Mike Lee are fighting for patients as they work to lower drug prices. That’s why today, Patients For Affordable Drugs Now launched a campaign to thank the senators for their leadership in the fight to lower drug prices and encourage each to support a key bill in the Senate that would protect Americans from unjustified drug price hikes.

Watch the ad campaign videos featuring a patient named Ashley for Sen. Romney and Sen. Lee.

Currently, the average American pays two to three times more for prescription drugs than citizens in other wealthy countries. The Prescription Drug Pricing Reduction Act of 2019 would curtail runaway drug price hikes in America and cap out-of-pocket costs for patients on Medicare, who can face more than $15,000 a year in drug costs.

“President Trump supports the Senate bill, and now we’re asking Senators Mitt Romney and Mike Lee to cosponsor this important bipartisan legislation,” said David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs Now. “Senator Romney has supported the FAIR Drug Pricing Act and Sen. Lee is a cosponsor of the CREATES Act, which would curtail anticompetitive practices. We want the senators to know patients are grateful and ask them to keep fighting by supporting the Senate bill.”

Today’s ads are part of the multi-million dollar campaign Patients For Affordable Drugs Now launched last month that features patients speaking out in support of proposals in the House and Senate to rein in skyrocketing drug prices. The campaign features TV, digital, and radio ads across the country that show the toll high prescription drug prices are taking on everyday Americans. In addition to paid media, the effort features visits from patients to Washington to share their stories in person and gives patients a suite of tools to contact their representatives in support of lowering drug prices.

Big Pharma is spending millions to distort, demonize, and relentlessly attack these proposals because the changes could actually break the rigged system that keeps pharma profits high and patients’ costs skyrocketing.

Americans overwhelmingly support action to lower drug prices. Eighty-six percent of Americans — majorities of Democrats, Republicans, and Independents — support allowing Medicare to negotiate. Nearly 1 in 3 adults report not taking their medicines as prescribed due to cost.

The mission of Patients For Affordable Drugs Now is to educate the public and mobilize patients to advocate for policies to curb runaway drug prices in America. Touted by The Hill as “a leading drug pricing advocacy group,” Patients For Affordable Drugs Now is a bipartisan non-profit organization established under Section 501(c)(4) of the Internal Revenue Service code. As a 501(c)(4), P4ADNow engages in electoral activity and direct advocacy in support of legislation that would lower drug prices.

###